TGH Cancer Institute Uses AI Technology for Precision Radiosurgery
TAMPA, Fla. – Tampa General Hospital’s Cancer Institute is revolutionizing cancer treatment with the use of advanced AI technology for precision radiosurgery. The institute is providing cutting-edge care for patients with benign and cancerous tumors, as well as those with neurological disorders.
Dr. Brian Collins, the Director of Radio Surgery at TGH Brandon Outpatient Center, is at the forefront of this innovative approach. Recently, he has been treating Melina Johnson, a patient diagnosed with melanoma and multiple masses in her head.
Johnson initially experienced severe headaches, which led to the discovery of the tumors. To address this complex condition, Dr. Collins turned to the CyberKnife S 7, an AI-powered tool that delivers highly focused radiation to specific targets within the body.
The CyberKnife’s precision is essential for treating conditions like melanoma, which require a high dose of radiation delivered with utmost accuracy. By utilizing this advanced technology, Dr. Collins can target the cancerous masses effectively, ensuring optimal outcomes for patients like Johnson.
During Johnson’s treatment sessions, she is fitted with a specialized mask to keep her head in place for precise radiation delivery. The non-invasive nature of the CyberKnife allows Johnson to resume her normal activities without any downtime following each session.
Dr. Collins emphasizes the significance of AI technology in modern radiation therapy, highlighting its ability to deliver radiation more effectively than traditional methods. With the CyberKnife, the treatment process is streamlined, offering patients like Johnson a sense of hope and assurance in their cancer treatment journey.
As radio surgery continues to evolve, AI-enabled tools like the CyberKnife are becoming integral to cancer treatment, providing patients with targeted and efficient care. The combination of advanced technology and personalized treatment plans is shaping the future of oncology, offering new possibilities for patients seeking effective and minimally invasive therapies.
